Anas, Baby Girl .

HRN: 27-87-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/29/2025
10/06/2025
IV
38mg
Q 24
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: